Endovia Health Sciences, Inc. 10-K

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. The Company’s Common Stock and tradeable warrants are quoted on the NYSE American under the symbol “SBEV” and “SBEV WS”. Aggregate Number of Holders of Common Stock As of March 31, 2023, there were 41,085,520 shares of Common Stock issued and outstanding. As of March 31, 2023, at our transfer agent and non-objecting beneficial owners totaled approximately 4,800 holders of record of our Common Stock. Dividends We have not declared any cash dividends on our common stock since inception and do not anticipate paying such dividends in the foreseeable future. We plan to retain any future earnings for use in our business operations. Any decisions as to future payment of cash dividends will depend on our earnings and financial position and such other factors as the Board of Directors deems relevant. Securities Authorized for Issuance under Equity Compensation Plans None. Equity Compensation Plan Information The following table gives information as of December 31, 2022, the end of the most recently completed fiscal year, about shares of common stock that have been issued under our Splash Beverage Group, Inc. 2020 Incentive Plan. Under the 2020 Incentive Plan we have 1,151,000 options outstanding as of December 31, 2022. See Note 6. Plan Category No. of Shares to be Issued Upon Exercise or Vesting of Outstanding Stock Options Weighted Average Exercise Price of Outstanding Stock Options Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans Equity compensation plan approved by board of directors 1,151,000 2.56 1,899,509 Total 1,151,000 2.56 1,899,509 24 Purchases of Equity Securities by the Issuer. There were no repurchase of our common stock during the year ended December 31, 2022. Item 6. Selected Financial Data. This item is not required for Smaller Reporting Companies.